Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier

Martin Bauer; Rudolf Karch; Markus Zeitlinger; Johann Stanek; Cecile Philippe; Wolfgang Wadsak; Markus Mitterhauser; Walter Jager; Helmuth Haslacher; Markus Muller; Oliver Langer

doi:10.2967/jnumed.112.118232

Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier

Martin Bauer, Rudolf Karch, Markus Zeitlinger, Johann Stanek, Cecile Philippe, Wolfgang Wadsak, Markus Mitterhauser, Walter Jager, Helmuth Haslacher, Markus Muller, Oliver Langer

Department für Mikrobiologie, Immunbiologie und Genetik

Veröffentlichungen: Beitrag in Fachzeitschrift › Artikel › Peer Reviewed

Originalsprache	Englisch
Seiten (von - bis)	1181-1187
Seitenumfang	0
Fachzeitschrift	The Journal of Nuclear Medicine
Jahrgang	54
Ausgabenummer	8
DOIs	https://doi.org/10.2967/jnumed.112.118232
Publikationsstatus	Veröffentlicht - 2013

ÖFOS 2012

301208 Pharmazeutische Technologie
106023 Molekularbiologie

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.2967/jnumed.112.118232

Zitationsweisen

Bauer, M., Karch, R., Zeitlinger, M., Stanek, J., Philippe, C., Wadsak, W., Mitterhauser, M., Jager, W., Haslacher, H., Muller, M., & Langer, O. (2013). Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier. The Journal of Nuclear Medicine, 54(8), 1181-1187. https://doi.org/10.2967/jnumed.112.118232

@article{c0cd7c0343d54ab2aaad3f7064548727,

title = "Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier",

author = "Martin Bauer and Rudolf Karch and Markus Zeitlinger and Johann Stanek and Cecile Philippe and Wolfgang Wadsak and Markus Mitterhauser and Walter Jager and Helmuth Haslacher and Markus Muller and Oliver Langer",

note = "Times Cited: 0 0",

year = "2013",

doi = "10.2967/jnumed.112.118232",

language = "English",

volume = "54",

pages = "1181--1187",

journal = "The Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine",

number = "8",

}

Bauer, M, Karch, R, Zeitlinger, M, Stanek, J, Philippe, C, Wadsak, W, Mitterhauser, M, Jager, W, Haslacher, H, Muller, M & Langer, O 2013, 'Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier', The Journal of Nuclear Medicine, Jg. 54, Nr. 8, S. 1181-1187. https://doi.org/10.2967/jnumed.112.118232

TY - JOUR

T1 - Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier

AU - Bauer, Martin

AU - Karch, Rudolf

AU - Zeitlinger, Markus

AU - Stanek, Johann

AU - Philippe, Cecile

AU - Wadsak, Wolfgang

AU - Mitterhauser, Markus

AU - Jager, Walter

AU - Haslacher, Helmuth

AU - Muller, Markus

AU - Langer, Oliver

N1 - Times Cited: 0 0

PY - 2013

Y1 - 2013

U2 - 10.2967/jnumed.112.118232

DO - 10.2967/jnumed.112.118232

M3 - Article

SN - 0161-5505

VL - 54

SP - 1181

EP - 1187

JO - The Journal of Nuclear Medicine

JF - The Journal of Nuclear Medicine

IS - 8

ER -